Radcliffe Capital Management, L.P. - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTAC and the CUSIP is 58507N105. A total of 69 filers reported holding MEDTECH ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q3 2022$4,632,000
+13.1%
466,487
+12.1%
0.11%
+19.1%
Q2 2022$4,096,000
+1.0%
416,087
+0.6%
0.09%
+2.2%
Q1 2022$4,054,000
-0.8%
413,6870.0%0.09%
-14.0%
Q4 2021$4,087,000
-0.5%
413,6870.0%0.11%
-10.8%
Q3 2021$4,108,000
+2.2%
413,687
-0.2%
0.12%
-4.8%
Q2 2021$4,021,000
+0.4%
414,5840.0%0.13%
-21.2%
Q1 2021$4,005,000414,5840.16%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q4 2021
NameSharesValueWeighting ↓
DARK FOREST CAPITAL MANAGEMENT LP 348,547$3,495,9270.86%
SkyView Investment Advisors, LLC 150,000$1,5050.46%
Magnetar Financial LLC 1,145,828$11,5040.20%
METEORA CAPITAL, LLC 24,063$241,3520.05%
Virtu Financial LLC 12,320$1240.02%
BOOTHBAY FUND MANAGEMENT, LLC 15,980$160,2790.00%
UBS Group AG 2,059$20,6520.00%
GEODE CAPITAL MANAGEMENT, LLC 17,239$1730.00%
MORGAN STANLEY 4,050$40,6220.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of MEDTECH ACQUISITION CORP shareholders